International Congress Munich 2014


New diagnostics and better treatments for multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)

Symposium
Chairs: F. Cobelens (Amsterdam, Netherlands), G. Guenther (Borstel, Germany)
Aims: This symposium will provide information on the mechanisms of drug resistance in M.tuberculosis.
World-leading experts will present the latest information regarding the epidemiology of M/XDR-TB, especially in Europe, which is where the majority of cases worldwide are identified. The priorities in M/XDR-TB care and research will also be defined, and the latest information on new drugs and new guidelines for the management of patients with M/XDR-TB will be provided.
Rapid identification of Mycobacterium TB drug resistance: from bench to bedside
E. Boettger (Zurich, Switzerland)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
The impact of drug resistance on TB control and elimination
J. Saukkonen (West Roxbury, United States of America)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
The top 10 questions that should be addressed to turn the tide in M/XDR-TB
M. Grobusch (Amsterdam, Netherlands)
No content made available
No content made available
Re-tooling existing drugs and the development of new drugs for the treatment of patients with M/XDR-TB
C. Lienhardt (Geneva, Switzerland)
No content made available
No content made available